Assessing of antibiotic resistance in the phage-plasmids of Klebsiella pneumoniae and its inhibitory compound
Gaceta Médica de México · 2025
DOI: 10.24875/gmm.25000061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gaceta Médica de México, 2025. Verfasst von Ragıp Soner-Silme. Beteiligte Einrichtung: Center for Research and Practice in Biotechnology and Genetic Engineering, Istanbul University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Plasmids, Bacteriophages, Drug Resistance, Bacterial.
Abstract (Originalsprache)
BACKGROUND: Antibiotic resistance in Klebsiella pneumoniae poses an increasing risk to human health worldwide. OBJECTIVES: Whole-genome sequence data were used to characterize K. pneumoniae phage-plasmids isolated in different countries. MATERIALS AND METHODS: Sequences of 15 genetically similar phage-plasmids were selected based on BLASTN analysis. Antibiotic resistance genes were screened using ResFinder, PhageAI, PlasmidFinder, PHASTEST, and PhageGE tools. Phage-plasmid sequences were then analyzed for a stable region in the genome using MAUVE analysis, and the protein of this stable region and its candidate inhibitor molecule were analyzed through molecular docking studies. RESULTS: Several resistance genes were detected in 7 of the 15 phage-plasmids screened. All plasmids had the Salmonella SSU5 prophage. MAUVE analysis indicated a common stable region encoding replication protein A. Molecular docking studies demonstrated that an interaction occurs between replication protein A and a fabimycin derivative. CONCLUSION: Fabimycin could be used to control both phage plasmids and their host, which could affect the severity and incidence of K. pneumoniae infections. ANTECEDENTES: La resistencia a los antibióticos en Klebsiella pneumoniae representa un riesgo creciente para la salud humana en todo el mundo. OBJETIVOS: Se utilizaron datos de secuencias completas del genoma para caracterizar los fagoplásmidos de K. pneumoniae aislados en diferentes países. MÉTODOS: Se seleccionaron secuencias de 15 fagoplásmidos genéticamente similares mediante el análisis BLASTN. Se analizaron los genes de resistencia a los antibióticos con las herramientas ResFinder, PhageAI, PlasmidFinder, PHASTEST y PhageGE. Posteriormente, se analizaron las secuencias de fagoplásmidos en busca de una región estable en el genoma mediante el análisis MAUVE, y la proteína de esta región estable y su molécula inhibidora candidata se analizaron mediante estudios de acoplamiento molecular. RESULTADOS: Se detectaron varios genes de resistencia en 7 de los 15 fagoplásmidos analizados. Todos los plásmidos contenían el profago SSU5 de Salmonella. El análisis MAUVE indicó una región estable común que codifica la proteína de replicación A. Estudios de acoplamiento molecular demostraron que existe una interacción entre la proteína de replicación A y un derivado de la Fabimicina. CONCLUSIONES: La Fabimicina podría utilizarse para controlar tanto los plásmidos fágicos como a su huésped, lo que podría afectar la gravedad e incidencia de las infecciones por K. pneumoniae.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Research and Practice in Biotechnology and Genetic Engineering, Istanbul University, Istanbul, Turkey.
Zitieren
APA
Soner-Silme, R. (2025). Assessing of antibiotic resistance in the phage-plasmids of Klebsiella pneumoniae and its inhibitory compound. Gaceta Médica de México. https://doi.org/10.24875/gmm.25000061
Vancouver
Soner-Silme R. Assessing of antibiotic resistance in the phage-plasmids of Klebsiella pneumoniae and its inhibitory compound. Gaceta Médica de México. 2025. doi:10.24875/gmm.25000061
BibTeX
@article{SonerSilme2025,
author = {Soner-Silme, Ragıp},
title = {Assessing of antibiotic resistance in the phage-plasmids of Klebsiella pneumoniae and its inhibitory compound},
journal = {Gaceta Médica de México},
year = {2025},
doi = {10.24875/gmm.25000061}
}
EUVIMED